Verisk Analytics, Inc. 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K, dated August 7, 2025 (with events reported through August 21, 2025), details Verisk Analytics, Inc.'s entry into material definitive agreements to finance the acquisition of Exactlogix, Inc. d/b/a AccuLynx.com ("AccuLynx"). The filing outlines the establishment of new credit facilities and the issuance of senior notes to fund the transaction.
Key Financial Metrics and Capital Structure
- Senior Notes Issuance: The Company agreed to sell $750 million of 4.500% Senior Notes due 2030 and $750 million of 5.125% Senior Notes due 2036, totaling $1.5 billion in new long-term debt.
- Term Credit Facility: A new three-year delayed draw term loan facility of $750 million was established to finance the AccuLynx acquisition.
- Revolving Credit Facility: The Company refinanced its existing revolving credit facility, increasing the aggregate principal amount to $1.25 billion and extending the maturity to August 15, 2030.
- Interest Rates: Borrowings under the credit facilities bear interest at Term SOFR (or alternative rates) plus an applicable margin ranging from 100 to 162.5 basis points, or a base rate plus 0 to 62.5 basis points, based on credit ratings.
- Financial Covenants: The Credit Agreements require a consolidated interest coverage ratio of not less than 3.00:1.00 and a consolidated funded debt leverage ratio of not greater than 3.75:1.00 (with temporary step-ups available for permitted acquisitions).
Material Changes and Transactions
The primary material change is the restructuring of the Company's debt profile to support the AccuLynx acquisition. The Company terminated a prior $1.5 billion 364-day bridge loan commitment in favor of the permanent financing described above. The new Revolving Credit Facility replaces the Second Amended and Restated Credit Agreement dated April 22, 2015. The Term Facility is contingent upon the consummation of the AccuLynx acquisition and will automatically terminate if the deal is not closed or the Merger Agreement is terminated.
Outlook, Risks, and Contingencies
- Use of Proceeds: Net proceeds from the Senior Notes, combined with the Term Facility and cash on hand, will fund the AccuLynx purchase price and related fees.
- Special Mandatory Redemption: If the AccuLynx acquisition is not consummated by January 5, 2026 (or an extended date), or if the Merger Agreement is terminated, the Company is required to redeem the Senior Notes at 101% of the principal amount plus accrued interest.
- Restrictions: The Indenture restricts the Company's ability to incur liens, enter into sale and leaseback transactions, and consolidate or merge assets. It also includes change of control repurchase provisions.
- Redemption Options: The 2030 Notes may be redeemed at a "make-whole" price prior to July 15, 2030, and at par thereafter. The 2036 Notes may be redeemed at a "make-whole" price prior to November 15, 2035, and at par thereafter.
Investor Verification Checklist
- Verify the closing status and timeline of the AccuLynx acquisition, as the Term Facility and Special Mandatory Redemption of the Senior Notes are contingent on this event.
- Review the full text of the Term Credit Agreement (Exhibit 10.1) and Third Amended and Restated Credit Agreement (Exhibit 10.2) for specific conditions precedent and covenant details.
- Confirm the Company's current credit ratings from S&P, Moody's, or Fitch to determine the applicable interest rate margins on the new credit facilities.
- Monitor the "Special Mandatory Redemption End Date" to assess the risk of forced redemption of the $1.5 billion in Senior Notes if the acquisition is delayed or terminated.
- Examine the Sixth Supplemental Indenture (Exhibit 4.1) for specific lien restrictions and change of control provisions.